share_log

啓明醫療-B:2023年度股東大會通告

VENUS MEDTECH-B: NOTICE OF 2023 ANNUAL GENERAL MEETING

HKEX ·  Jun 7, 2024 10:03

Summary by Moomoo AI

啟明醫療-B(股份代號:2500)將於2024年6月28日下午2時,在中國杭州召開2023年度股東大會。會議將審議包括年度報告、董事會及監事會工作報告、利潤分配方案以及續聘審計師等議案。股東大會相關文件將於2024年6月7日發布。H股股份過戶登記將於6月25日至28日暫停,並規定股東出席大會及投票的相關手續。公司執行董事林浩昇先生於2024年6月7日發出通告。
啟明醫療-B(股份代號:2500)將於2024年6月28日下午2時,在中國杭州召開2023年度股東大會。會議將審議包括年度報告、董事會及監事會工作報告、利潤分配方案以及續聘審計師等議案。股東大會相關文件將於2024年6月7日發布。H股股份過戶登記將於6月25日至28日暫停,並規定股東出席大會及投票的相關手續。公司執行董事林浩昇先生於2024年6月7日發出通告。
Qiming Medical-B (Stock Code: 2500) will hold the 2023 Shareholders' Meeting in Hangzhou, China at 2 pm on June 28, 2024. The meeting will review agendas including the annual report, reports on the work of the Board of Directors and the Supervisory Board, profit distribution plans, and the re-appointment of auditors. Relevant documents for the shareholders' meeting will be released on June 7, 2024. The transfer registration of H shares will be suspended from June 25 to 28, 2024, and shareholders are required to complete relevant procedures to attend and vote at the meeting. Mr. Lin Haosheng, the Executive Director of the company, issued a notice on June 7, 2024.
Qiming Medical-B (Stock Code: 2500) will hold the 2023 Shareholders' Meeting in Hangzhou, China at 2 pm on June 28, 2024. The meeting will review agendas including the annual report, reports on the work of the Board of Directors and the Supervisory Board, profit distribution plans, and the re-appointment of auditors. Relevant documents for the shareholders' meeting will be released on June 7, 2024. The transfer registration of H shares will be suspended from June 25 to 28, 2024, and shareholders are required to complete relevant procedures to attend and vote at the meeting. Mr. Lin Haosheng, the Executive Director of the company, issued a notice on June 7, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more